GH1 and adenoma: In initial studies in primary cultures of human GH-secreting adenoma cells, it was observed that whereas both pure SRIF and pure dopamine analogs were able to induce dose-related suppression of GH secretion, the combination of the two individual agents produced no greater suppression of GH than the SRIF analog alone.